Laboratorios Richmond SACIF (RICH)
BCBA BCBA Primary Summary
Laboratorios Richmond SACIF (RICH) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Laboratorios Richmond SACIF ever had a stock split?
Laboratorios Richmond SACIF Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Juan Manuel Artola CEO | BCBA Exchange | ARLRIC300027 ISIN |
| Argentina Country | 620 Employees | 12 Jun 2026 Last Dividend | - Last Split | - IPO Date |
Overview
Laboratorios Richmond S.A.C.I.F. is a pioneering pharmaceutical company based in Buenos Aires, Argentina, with a rich history dating back to its foundation in 1935. The company specializes in the development and manufacturing of a diverse range of pharmaceutical products, focusing on addressing various medical conditions and improving patient care. They have established a strong market presence not only in their home country but also across Latin America, Africa, Asia, and the Middle East, reflecting their commitment to global health improvement and accessibility to essential medications.
Products and Services
Laboratorios Richmond S.A.C.I.F. offers an extensive portfolio of pharmaceutical products across several therapeutic areas, reflecting their expertise and innovation in drug development. Some of their key products and services include:
- Antiretroviral Products: Specialized in combating human immunodeficiency virus (HIV), these drugs are central to the company's mission of supporting individuals living with HIV/AIDS, aiming to enhance their quality of life and promote long-term health.
- Oncology and Oncohematology Drugs: Developing treatments for cancer and blood disorders, the company aims to provide effective solutions for some of the most challenging diseases, focusing on improving survival rates and the quality of life for patients.
- Cardiometabolic Drugs: This category includes a range of treatments for cardiovascular and metabolic conditions, such as antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs. These products underscore the company's commitment to addressing the global burden of these diseases.
- Neurological and Psychiatric Drugs: Offering a diverse array of treatments for conditions affecting the mind and nervous system, including analgesic, antipsychotic, antidepressants, anti-dementia, antiepileptics, and hypnotic drugs, as well as treatments for multiple sclerosis. This demonstrates their dedication to advancing mental health and neurological care.
